Population-Based Estimates of the Prevalence of Family History of Cancer among WomenHall I.J.a · Burke W.b · Coughlin S.a · Lee N.C.a
aDivision of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Ga., and bDepartment of Medical History and Ethics, University of Washington, Seattle, Wash., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Objective: Family history of cancer is recognized as one of the most important risk factors in predicting personal cancer risk. Nevertheless, there are few published population-based estimates of family history prevalence by age categories. Methods: We used responses of female controls (n = 4,754) from the population-based Cancer and Steroid Hormone study (1980–1982) to estimate the frequency of family history of various cancers among female relatives. We determined the age- and race-specific prevalence of family history of breast, ovarian, endometrial, and other cancers in first-degree female relatives of women aged 20–54 years. To evaluate changes in reporting family history over time, we also analyzed responses of control women (n = 1,544) from the Women’s Interview Study on Health (WISH) (1990–1992) to estimate the prevalence of family history of breast cancer. Results: The prevalence of a first-degree family history of breast, ovarian, endometrial, and cervical cancers was 6.4% (95% CI 5.7–7.1%), 1.1% (0.8–1.4%), 3.5% (3.0–4.0%), and 2.1% (1.7–2.5%), respectively. Among first-degree female relatives, the prevalence of family history of colon, lung, and thyroid cancers was 2.4% (2.1–2.9%), 1.5% (1.2–1.8%), and 0.5% (0.3–0.7%), respectively. The prevalence of family history of breast and colon cancers increased significantly with respondent’s age. Similar results for family history of breast cancer were obtained from an analysis of responses from the WISH. Conclusions: In addition to providing a point of reference for research and health policy, these results may be of interest to providers who care for female patients because of the usefulness of information about family history of cancer for assessing lifetime risk of cancer.
© 2002 S. Karger AG, Basel
- Ghadirian P, Lacroix A, Perret C, Maisonneuve P, Boyle P: Sociodemographic characteristics, smoking, medical and family history, and breast cancer. Cancer Detect Prev 1998;22:485–494.
- Ghadirian P, Maisonneuve P, Perret C, Lacroix A, Boyle P: Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: A case-control study among French Canadians in Montreal. Cancer Detect Prev 1998;22:396–404.
- Fioretti F, Tavani A, Bosetti C, La Vecchia C, Negri E, Barbone F, Talamini R, Franceschi S: Risk factors for breast cancer in nulliparous women. Br J Cancer 1999;79:1923–1928.
- Magnusson C, Colditz G, Rosner B, Bergstrom R, Persson I: Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control 1998;9:259–267.
Sattin RW, Rubin GL, Webster LA, Huezo CM, Wingo PA, Ory HW, Laude PM: Family history and the risk of breast cancer. JAMA 1995;253:1908–1913.
- Lynch HAT, Watson P, Conway T, Fitzsimmons ML, Lynch J: Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 1988;11:263–267.
- Negri E, Braga C, La Vecchia C, Franceschi S, Parazzini F: Family history of cancer and risk of breast cancer. Int J Cancer 1997;72:735–738.
- Bhatia S, Pratt CB, Sharp GB, Robinson LL: Family history of cancer in children and young adults with colorectal cancer. Med Pediatr Oncol 1999;33:470–475.
- Newcomb PA, Taylor JO, Trentham-Dietz A: Interactions of familial and hormonal risk factors for large bowel cancer in women. Int J Epidemiol 1999;28:603–608.
- Kerber RA, Slattery ML, Potter JD, Caan BJ, Edwards SL: Risk of colon cancer associated with a family history of cancer or colorectal polyps: The diet, activity, and reproduction in colon cancer study. Int J Cancer 1998;78:157–160.
- Le Marchand L, Zhao LP, Quiaoit F, Wilkens LR, Kolonel LN: Family history and risk of colorectal cancer in the multiethnic population of Hawaii. Am J Epidemiol 1996;144:1122–1128.
- Mink PJ, Folsom AR, Sellers TA, Kushi LH: Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: A follow-up study of older women. Epidemiology 1996;7:38–45.
- Kerber RA, Slattery ML: The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med 1995;155:905–912.
- Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA: A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 1998;105:493–499.
- Schildkraut JM, Thompson WD: Familial ovarian cancer: A population-based case-control study. Am J Epidemiol 1988;128:456–466.
- Glover FE Jr, Coffey DS, Douglas L, Russell H, Cadigan M, Tulloch T, Wedderburn K, Wan RL, Baker TD, Walsh PC: Familial study of prostate cancer in Jamaica. Urology 1998;52:441–443.
- Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP: Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999;8:53–60.
- Bratt O, Kristoffersson U, Lundgren R, Olsson H: Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 1999;35:272–277.
- Rodriguez C, Callee EE, Miracle-McMahill HL, Tatham LM, Wingo PA, Thun MJ, Heath CW Jr: Family history and risk of fatal prostate cancer. Epidemiology 1997;8:653–657.
- Lesko SM, Rosenberg L, Shapiro S: Family history and prostate cancer risk. Am J Epidemiol 1996;144:1041–1047.
- Schuurman AG, Zeegers MP, Goldbohm RA, Van den Brandt PA: A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology 1999;10:192–195.
- Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T: Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 1995;141:732–740.
- Whiteman DC, Valery P, McWhirter W, Green AC: Risk factors for childhood melanoma in Queensland, Australia. Int J Cancer 1997;70:26–31.
- Cutler C, Foulkes WD, Brunet JS, Flanders TY, Shibata H, Narod SA: Cutaneous malignant melanoma in women is uncommonly associated with a family history of melanoma in first-degree relatives: A case-control study. Melanoma Res 1996;6:435–440.
- Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM: Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 1999;135:261–265.
- Masback A, Westerdahl J, Ingvar C, Olsson H, Jonsson N: Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma: A population-based study. Melanoma Res 1999;9:189–197.
- Gruber SB, Thompson WD: A population-based study of endometrial cancer and familial risk in younger women. The Cancer and Steroid Hormone Study Group. Cancer Epidemiol Biomarkers Prev 1996;5:411–417.
- Brown LM, Linet MS, Greenberg RS, Silverman DT, Hayes RB, Swanson GM, Schwartz AG, Schoenberg JB, Pottern LM, Fraumeni JF Jr: Multiple myeloma and family history of cancer among blacks and whites in the US. Cancer 1999;85:2385–2390.
- McCahy PJ, Harris CA, Neal DE: Breast and prostate cancer in the relatives of men with prostate cancer. Br J Urol 1996;78:552–556.
- Claus EB, Risch N, Thompson WD: The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat 1993;28:115–120.
- Thompson WD, Schildkraut JM: Family history of gynaecological cancers: Relationships to the incidence of breast cancer prior to age 55. Int J Epidemiol 1991;20:595–602.
- Rodriguez C, Callee EE, Tatham L, Wingo PA, Miracle-McMahill HL, Thun MJ, Heath CW Jr: Family history of breast cancer as a predictor for fatal prostate cancer. Epidemiology 1998;9:525–529.
- Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W, Folsom AR: Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst 1994;86:1860–1865.
- Anderson DE, Badzioch MD: Familial breast cancer risks. Effects of prostate and other cancers. Cancer 1993;72:114–119.
Schildkraut JM, Thompson WD: Relationship of epithelial ovarian cancer to other malignancies within families. Genetic Epidemiol 1998;5:355–367.
- Yang Q, Khoury MJ, Rodriguez C, Calle EE, Tatham LM, Flanders WD: Family history score as a predictor of breast cancer mortality: Prospective data from the Cancer Prevention Study II, United States, 1982–1991. Am J Epidemiol 1998;147:652–659.
- Claus EB, Risch N, Thompson WD: Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:244–253.
- Schwartz AG, King MC, Belle SH, Satariano WA, Swanson GM: Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985;75:665–668.
- Egan KM, Stampfer MJ, Rosner BA, Trichopoulos D, Newcomb PA, Trentham-Dietz A, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC: Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev 1998;7:359–364.
- Weber W: Cancer control by family history. Anticancer Res 1993;13:1197–1201.
- Brzezinski W, Orrom WJ, Wiens E: Prospective and retrospective analysis of colonoscopy findings in patients with a history of colorectal carcinoma in first-degree relatives. Can J Surg 1990;33:314–316.
- Sellers TA, Bazyk AE, Bostick RM, Kushi LH, Olson JE, Anderson KE, Lazovich D, Folsom AR: Diet and risk of colon cancer in a large prospective study of older women: An analysis stratified on family history. Cancer Causes Control 1998;9:357–367.
- Keller G, Rudelius M, Vogelsang H, Grimm V, Wilhelm MG, Mueller J, Siewert JR, Hofler J: Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history. Am J Pathol 1998;152:1281–1289.
- Johnson N, Lancaster T, Fuller A, Hodgson SV: The prevalence of a family history of cancer in general practice. Fam Pract 1995;12:287–289.
Wingo PA, Ory HW, Layde PM, Lee NC: The evaluation of the data collection process for a multicenter, population-based, case-control design. Am J Epidemiol 1998;128:206–217.
- Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN: Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87:827–835.
- Lipkus IM, Iden D, Terrenoire J, Feaganes JR: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:533–539.
- Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, Balshem A: Effects of individualized breast cancer risk counseling: A randomized trial. J Natl Cancer Inst 1995;87:286–292.
- Audrain J, Lerman C, Rimer B, Cella D, Steffens R, Gomez-Caminero A: Awareness of heightened breast cancer risk among first-degree relatives of recently diagnosed breast cancer patients. The High Risk Breast Cancer Consortium. Cancer Epidemiol Biomarkers Prev 1995;4:561–565.
- Inglehart JD, Miron A, Rimer BK, Winter EP, Berry D, Schildkraut JM: Overestimation of hereditary breast cancer risk. Ann Surg 1998;228:375–384.
- Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651.
- Douglas FS, O’Dair LC, Robinson M, Evans DG, Lynch SA: The accuracy of diagnoses as reported in families with cancer: A retrospective study. J Med Genet 1999;36:309–312.
- Glanz K, Grove J, LeMarchand L, Gotay C: Underreporting of family history of colon cancer: Correlates and implications. Cancer Epid Biomarkers Prev 1999;8:635–639.
American Cancer Society, Cancer Facts and Figures – 1999. Atlanta, GA.
SEER Cancer Statistics Review, 1973–1996. Bethesda, National Cancer Institute, 1999, NIH Publ No 97-2789.
- Parent ME, Ghadirian P, Lacroix A, Perret C: The reliability of recollections of family history: Implications for the medical provider. J Cancer Educ 1997;12:114–120.
- Kerber RA, Slattery ML: Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997;146:244–248.
- Anton-Culver H, Kurosaki T, Taylor TH, Gildea M, Brunner D, Bringman D: Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population-based cancer registry. Genetic Epidemiol 1996;13:193–203.
- Bergmann MM, Calle EE, Mervis CA, Miracle-McMahill HL, Thun MJ, Heath CW: Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 1998;147:556–562.
- Weinstock MA, Brodsky GL: Bias in the assessment of family history of melanoma and its association with dysplastic nevi in an case-control study. J Clin Epidemiol 1998;51:1299–1303.
- Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789–792.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.